These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1143390)

  • 1. Proceedings: Age dependent recovery of rat brain MAO activity after administration of a single dose of iproniazid and pargyline.
    Sprengeler T; Rakow D; Schulze G; Christ W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R12. PubMed ID: 1143390
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of ethanol consumption on the sensitivity of rat brain monoamine oxidases to the inhibition by pargyline in vivo and in vitro.
    Panova NG; Axenova LN; Medvedev AE
    Neurobiology (Bp); 2000; 8(3-4):225-30. PubMed ID: 11225512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of iproniazid phosphate and pargyline hydrochloride on oxygen consumption, glucose and mitochondrial oxidative phosphorylation of the rat brain in vitro].
    González Martínez JL; Saiz I; Velasco A; García de Jalón PD
    Arch Farmacol Toxicol; 1977 Dec; 3(3):259-66. PubMed ID: 613983
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective brain monoamine oxidase inhibition resulting from an interaction between reversible and irreversible inhibitors.
    Horita A
    Int J Neuropharmacol; 1965 Nov; 4(6):337-42. PubMed ID: 4379937
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The labeling in vivo of monoamine oxidase by 14 C-pargyline: a tool for studying the synthesis of the enzyme.
    Erwin VG; Deitrich RA
    Mol Pharmacol; 1971 Mar; 7(2):219-28. PubMed ID: 5125856
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
    Neff NH; Costa E
    J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 10. The stimulating effects of ethanol consumption on synthesis of rat brain monoamine oxidases and their sensitivity to the irreversible inhibitor, pargyline.
    Panova NG; Axenova LN; Medvedev AE
    Neurosci Lett; 2000 Sep; 292(1):66-8. PubMed ID: 10996452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis of monoamine oxidase in subcellular structures in normal conditions and in alcoholism].
    Moskvitina TA
    Biomed Khim; 2006; 52(2):169-73. PubMed ID: 16805388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E; Reibert R
    Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of newly synthesized monoamine oxidase in subcellular fractions of the rat liver.
    Erwin VG; Simon RJ
    J Pharm Sci; 1969 Aug; 58(8):1033-5. PubMed ID: 5344520
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of dehydroepiandrosterone (DHEA) on monoamine oxidase activity, lipid peroxidation and lipofuscin accumulation in aging rat brain regions.
    Kumar P; Taha A; Sharma D; Kale RK; Baquer NZ
    Biogerontology; 2008 Aug; 9(4):235-46. PubMed ID: 18307051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of histochemical demonstration of monoamine oxidase in experimental pharmacology and its correlation with biochemical determination of monoamine oxidase activity.
    Meier-Ruge W; McFadden S; Zehnder K
    Med Pharmacol Exp Int J Exp Med; 1966; 14(2):152-60. PubMed ID: 5952033
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of age on the recovery of cardiac monoamine oxidase after irreversible inhibition.
    Horita A
    Biochem Pharmacol; 1968 Oct; 17(10):2091-6. PubMed ID: 5696878
    [No Abstract]   [Full Text] [Related]  

  • 17. A simple and sensitive spectrophotometric determination of monoamine oxidase activity.
    Christ W; Rakow D; Fernandes M; Magour S
    Z Klin Chem Klin Biochem; 1973 Sep; 11(9):367-70. PubMed ID: 4754111
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of monoamine oxidation in brain by monoamine oxidase inhibitors.
    Guha SR; Ghosh SK
    Biochem Pharmacol; 1970 Nov; 19(11):2929-32. PubMed ID: 5512700
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of monoamine oxidase inhibitors of various chemical nature on some indices of carbohydrate metabolism in the rabbit brain].
    Musialkovskaia AA
    Ukr Biokhim Zh; 1967; 39(2):119-24. PubMed ID: 5603054
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of thyroid monoamineoxidase by thyroxine and some specific inhibitors.
    Knopp J; Torda T
    Endokrinologie; 1979; 73(3):356-8. PubMed ID: 499103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.